Gustavo Adolfo Heresi Davila
- Cleveland Clinic Lerner College of Medicine · Internal Medicine (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #21,669
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10550240Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2026
Linked Award Amount
$814.8K
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#21,669
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Gustavo Adolfo Heresi Davila as a PI. Multi-PI records show the full award amount for context.
- 5UH3HL175041-03UH3Contact PI1/2 Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial HypertensionCleveland Clinic Lerner College of Medicine · Internal Medicine (NIH department code)$814.8Kaward amount
Award organization
Organizations that administered FY2026 awards listing Gustavo Adolfo Heresi Davila as a PI.
FY2026 award administered by Cleveland Clinic Lerner College of Medicine (OH).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardCleveland Clinic Lerner College of Medicine
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2026$2M Cumulative Funding